Lung cancer screening - State of the art;Screening des lungenkarzinoms - Aktueller stand

Pneumologie

Volumn 59, Issue 3, 2005, Pages 178-191

  Nowak, Dennis ^a   Ochmann, U ^a   Huber, R M ^b   Diederich, S ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MARIEN HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MORTALITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; SPUTUM ANALYSIS; STANDARDIZATION; THORAX RADIOGRAPHY; GERMANY; LUNG TUMOR; MASS SCREENING; OCCUPATIONAL DISEASE; STANDARD;

GERMANY; HUMANS; LUNG NEOPLASMS; MASS SCREENING; OCCUPATIONAL DISEASES; RADIOGRAPHY, THORACIC; RISK FACTORS;

EID: 17144418922     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830200     Document Type: Review

References (72)

1. Greenlee RT, Murray T, Bolden S et al. Cancer statistics. CA Cancer J Clin 2000; 50: 7-33
2. Arbeitsgemeinschaft bevölkerungsbezogener Krebsregister in Deutschland, in Zusammenarbeit mit dem Robert-Koch-Institut. "Krebs in Deutschland", 3.Ausgabe. Saarbrücken, 2002
3. Peto R, Darby S, Deo H et al. "Smoking, smoking cessation, and lung cancer in the UK since 1950". BMJ 2000; 321: 323-329
4. Lorenz D mit einem Beitrag von Nowak D. Checkliste XXL Pneumologie. Stuttgart: Thieme, 2004
5. Schön S, Nowak D. Medikamentöse Verfahren zur Raucherentwöhnung. Suchtmed 2002; 4: 189-199
6. American Cancer Society. Cancer facts and figures. Atlanta: ACS, 2001
7. Diderich AS, Lenzen H. Radiation exposure associated with imaging of the chest: Comparison of different radiographic and computed tomography techniques. Cancer 2000; 89: 2457-2460
8. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologix examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: 740-753
9. Becker N. Screening aus epidemiologischer Sicht. Radiologe 2002; 42: 592-600
10. Patz Jr EF, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000; 343: 1627-1633
11. Eddy DM. Screening for lung cancer. Ann Intern Med 1989; 111: 232-237
12. Strauss GM. The Mayo lung cohort: a regression analysis focusing on lung cancer incidence and mortality. J Clin Oncol 2002; 20: 1973-1983
13. Bepler G, Carney DG, Djulbegovic B et al. A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 2003; 10: 306-313
14. Manser RL, Irving LB, Byrnes G et al. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003; 58: 784-789
15. Van Klaveren RJ, Habbema JDF, Pedersen JH et al. Lung cancer screening by low-dose spiral computed tomography. Eur Respir J 2001; 18: 857-866
16. Diederich S, Wormanns D, Heindel W. Lungenkrebsfrüherkennung mit Low-dose-CT: ein Update. Radiologe 42; 2002: 608-611
17. Diederich S, Wormanns D, Heindel W. Lung cancer screening with low-dose CT. Eur J Radiol 2003; 45: 2-7
18. Wilde J. A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR. Eur Respir J 1989; 2: 656-662
19. Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968; 23: 414-420
20. Brett G. Earlier diagnosis and survival in lung cancer. BMJ 1969; 4: 260-262
21. Fontana RS, Sanderson DR, Woolner LB et al. Lung cancer screening: the Mayo program. J Occup Med 1986; 28: 746-750
22. Fontana RS, Sanderson DR, Woolner LB et al. Screening for lung cancer. A critique of the Mayo Lung project. Cancer 1991; 67 (4 suppl): 1155-1164
23. Marcus P, Bergstralh EJ, Fagerström RM et al. Lung cancer mortality in the Mayo Lung project: impact of extended follow-up. J Natl Cancer Inst 2000; 92: 1308-1316
24. Friedman G, Collen MF, Fireman BH. Multiplhasic health check up evaluation: a 16 year follow up. J Chron Dis 1986; 39: 453-463
25. Kubik A, Polak J. Lung cancer detection: results of a randomized prospective study in Czechoslovakia. Cancer 1986; 57: 2427-2437
26. Kubik A, Parkin DM, Khlat M et al. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomised controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990; 45: 26-33
27. Melamed MR, Flehinger BJ, Zaman MB et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86: 44-53
28. Tockman M, Frost JK, Stitik FP et al. Screening and detection of lung cancer. In: Aisner J (Hrsg.) Lung cancer. New York: Churchill Livingstone, 1985: 25-40
29. Henschke CI, McCauley Dl, Yankelevitz DF et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99-105
30. Henschke CI, McCauley DI, Yankelevitz DF et al. Early Lung Cancer Action Project: Initial findings on repeat screening. Cancer 2001; 92: 153-159
31. Sone S, Li F, Yang ZG et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001; 84: 25-32
32. Sone S, Takashima S, Li F et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351 (9111): 1242-1245
33. Diederich S, Wormanns D, Semik M et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002; 222: 773-781
34. Diederich S, Thomas M, Semik M et al. Screening for early low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004; 14: 691-702
35. Nawa T, Nakagawa T, Kusano S et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow up studies. Chest 2002; 122: 15-20
36. Sobue T, Moriyama N, Kaneko M et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002; 20: 911-920
37. Swensen SJ, Jett JR, Sloan JA et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165: 508-513
38. Swensen SJ, Jett JR, Sloan JA et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003; 226: 756-761
39. Swensen SJ, Crestanello JA, Allen MS et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovas Surg 2004 Aug; 128 (2): 254-259
40. Pastorino U, Bellomi M, Landoni C et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362: 593-597
41. Tiitola M, Kivisari L, Huuskonen MS et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002; 35: 17-22
42. Karp DD, Mulshine JL, Henschke CI. Non-small cell lung cancer: screening, new imaging and prevention. In: Perry MC (Hrsg.) American Society of Clinical Oncology. Educational Book. Philadelphia: WB Saunders Co, 2000: 487-502
43. Risse EKJ, Vooijs GP, Hof MA van't. Diagnostic significance of "severe dysplasia" in sputum cytology. Acta Cytol 1988; 32: 629-634
44. Venmans BJW, Boxem TJM van, Smit EF et al. Outcome of bronchial carcinoma in situ. Chest 2000; 117: 1572-1576
45. Marek W, Kotschy-Lang N, Muti A et al. Can semi-atumated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers. Eur Respir J 2001; 18: 942-950
46. Hirsch FR, Franklin WA, Gazdar AF et al. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001; 7: 5-22
47. Hirsch FR, Pridiville SA, Miller YE et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001; 43: 1385-1391
48. Tockman MS, Gupta PK, Myers JD et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988; 6: 1685-1693
49. Qiao Y-L, Tockman MS, Li L et al. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China. Cancer Epidemiol Biomarkers Prev 1997; 6: 893-900
50. Tockman MS, Mulshine JL, Piantadosi S et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997; 3: 2237-2246
51. Gazdar AF, Minna JD. Molecular detection of early lung cancer. J Natl Cancer Inst 1999; 91: 299-301
52. Mao L, Hruban RH, Boyle JO et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994; 54: 1634-1637
53. Miozzo M, Sozzi G, Musso K et al. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients. Cancer Res 1996; 56: 2285-2288
54. Kersting M, Friedl C, Kraus A et al. Differential frequencies of p16INK4a promotor hypermethylation, p53 mutation and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 2000; 18: 3222-3229
55. Virmani AK, Rathi A, Zöchbauer-Müller S et al. Promoter methylation and silencing of the retinoic acid receptor gene in lung carcinomas. J Natl Cancer Inst 2000; 92: 1303-1307
56. Zöchbauer-Müller S, Fong KM, Virmani AK et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001; 61: 249-255
57. Payne PW, Sebo TJ, Doudkine A et al. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clin Proc 1997; 72: 697-704
58. Lam S, MacAulay C. Endoscopic detection of preneoplastic lesions. In: Brambilla C, Brambilla E (Hrsg). Lung Tumors. Fundamental Biology and Clinical Management. Grenoble: Marcel Dekker, 1999: 473-480
59. Palcic B, Garner DM, Beveridge J et al. Increase of sensitivity of sputum cytology using high-resolution image cytometry: field study results. Cytometry 2002; 50: 168-176
60. McWilliams A, Mayo J, MacDonald S et al. Lung cancer screening. A different paradigm. Am J Respir Crit Care Med 2003; 168: 1167-1173
61. Field JK, Brambilla C, Caporaso N et al. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol 2002; 21: 369-373
62. Thunissen FBJM. Sputum examination for early detection of lung cancer. J Clin Pathol 2003; 56: 805-810
63. Woolner LB, Fontana RS, Cortesse DA et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1984; 59: 453-466
64. Huber RM, Gamarra F, Hautmann H et al. 5-Aminolaevulinic acid (ALA) for the fluorescence detection of bronchial tumors. Diagnostic and Therapeutic Endoscopy 1999; 5: 113-118
65. Schneider J, Peltri G, Bitterlich N et al. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Anticancer Res 2003; 23: 899-906
66. Nowak D, Magnussen H, Rüdiger HW. Exposition und Disposition in der Genese des Bronchialkarzinoms 43. Prax Klin Pneumol 1989; 43: 135-146
67. Nowak D. Anforderungen an Nachuntersuchungen bei anerkannter BK 4301/4302. In: Hauptverband der gewerblichen Berufsgenossenschaften (Hrsg.): Die Bedeutung von nachgehenden Untersuchungen von Berufskrankheiten, ISBN3-88383-638-9. 2003: 63-75
68. Kim YH, Lee KS, Primack SL et al. Small pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J Thoracic Imaging 2002; 17: 40-46
69. Miettinen O, Henschke C. CT screening for lung cancer: coping with nihilistic recommendations. Radiology 2001; 221: 592-596
70. Patz EF, Black WC, Goodmann PC. CT screening for lung cancer: not ready for routine practice. Radiology 2001; 221: 587-591
71. Patz EF, Black WC, Goodmann PC. Commentary on Drs Miettinen und Henschke's Viewpoint. Radiology 2001; 221: 597
72. Miettinen OS, Henschke CI. Commentary on Drs Patz, Black and Goodmann's Viewpoint. Radiology 2001; 221: 598-599